Pfizer CEO Profits After COVID Vaccine Announcement

MarketScale
MarketScale
Nov 30, 2020
Albert Bourla CEO Coronavirus COVID Daniel Litwin Podcast Moderna Pfizer profit shareholders Stock Tyler Kern Podcast Vaccine

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

IC-SAT100
Meet IC-SAT100, a Satellite PTT Radio Built for the World’s Most Demanding Environments
February 5, 2026

Let’s have a look at Icom’s IC-SAT100, a satellite Push-To-Talk radio designed for moments when ordinary communication just isn’t an option. Powered by the Iridium satellite network, this rugged handheld delivers instant one-to-many communication at the push of a button—no cell towers or ground infrastructure required. Built to thrive in harsh environments, it’s waterproof,…

Read More
IP110H
From Hospitals to Warehouses, the IP110H Keeps Your Team in Sync
February 5, 2026

Icom’s IP110H is a compact, license-free WLAN radio built to keep teams talking—clearly and instantly—over an existing wireless network. Designed for environments like hospitals, hotels, warehouses, and tunnels, it delivers real-time, full-duplex voice using Icom’s advanced IP radio system. From Bluetooth capability to USB-C charging and a sleek, pocket-friendly design, the IP110H feels modern,…

Read More
IP501H
The IP501H Brings Effortless, Wide-Area Communication to Your Team
February 4, 2026

Meet Icom’s IP501H, a cellular two-way radio built for instant wide-area communication over LTE (4G) and 3G networks. It works just like a traditional radio—supporting individual, group, and all-call conversations—without the need for repeaters or a dedicated IP network. With everything included in the box, the IP501H is designed for quick setup and fast…

Read More
IP730D
One Radio, Three Networks, Seamless Coverage: Meet the IP730D
February 4, 2026

Icom’s IP730D is a true game-changer in professional communications, blending LTE, IDAS, and analog networks into one powerful hybrid radio. Designed for flexibility and confidence in the field, it uses dual PTT buttons to let users transmit and receive across networks seamlessly—delivering reliable, wide-area coverage wherever it’s needed. From the moment it comes out of…

Read More
Related
AI in sterile processing
Software & Technology
AI in Sterile Processing Is Proving Its Value by Acting as a Co-Pilot, Not a Replacement
February 5, 2026
survey
Healthcare
Survey Ready Every Day: Why It’s Not Just a Once-a-Year Activity
January 13, 2026

Unannounced surveys are no longer the exception in healthcare—they’re the norm. Accrediting bodies increasingly expect sterile processing departments (SPDs) to demonstrate consistent compliance, real-time documentation, and reliable adherence to manufacturers’ instructions for use on any given day, not just during audit season. Joint Commission survey data continue to show that high-level disinfection and sterilization practices…

Read More
Dr. G. Duncan Finlay
Healthcare
The Legacy of Dr. G. Duncan Finlay – Episode 6
January 9, 2026

The Rothman Index, developed by Dr. Michael Rothman and his brother Steven, is a pioneering patient acuity score designed to help clinicians recognize patient deterioration earlier and more clearly. Presented as an easily understood, color-coded graph that updates in real time, the Index displays upward and downward trends in patient condition at a glance—transforming…

Read More